Searched for
RESPIRATORY DISORDER
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Can a cough reveal lung disease? Swaasa AI uses cough sound analysis to screen respiratory disordersAI-powered platform Swaasa is using cough sound analysis through smartphones to help screen respiratory diseases such as COPD, asthma and p...
- From care to commerce: How phydigital healthcare is turning patient programmes into big businessIndia's healthcare is changing. Value is moving from hospitals to patients' daily lives. A new 'phydigital' model combines physical and dig...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Not just hot days, hot nights are the real problem: Why heatwave health impact and risk increases after sunsetHot nights are emerging as a serious health risk, especially during ongoing heatwaves across India. When temperatures remain high after sun...
- Millions await VA checks: May 2026 payment date set—here’s when cash landsVA payment schedule 2026: US veterans awaiting their next benefit can mark their calendars. May 2026 VA disability compensation payments ar...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...
- Fake mango alert: 3,800 kg of chemically made pulp seized in Pune. Know side effects & how to identify artificially ripened aam at homeMango Adulteration Alert: With the mango season in full swing, rising cases of mango adulteration in India have sparked serious food safety...
- AIIMS researchers pioneer breakthrough diagnostic tool for rare genetic disordersResearchers at AIIMS-Delhi have pioneered a novel transmission electron microscopy technique for diagnosing Primary Ciliary Dyskinesia and ...
- 'Unusual' form of cell death underlies lung damage in Covid patients, finds studyFerroptosis, a less common cell death type, is linked to severe lung damage in Covid patients, causing inflammation and respiratory complic...
- India's pharma market grows 8% in '22 led by price hikesIn 2021, the market had shown a growth of 14.9%, primarily because of a low base, and the high volume offtake of Covid-19 and related medic...
- Can Covid affect mental health and brain disorders two years after infection?The study also saw an ongoing risk of psychosis and seizures in children.
- COVID-19 may increase risk of psychiatric disorder in months after infection: StudyThe study used data from the National COVID Cohort Collaborative (N3C) to match 46,610 COVID-19 positive individuals with control patients ...
- Neurological and mental disorders major risks for Covid patients, finds Oxford studyThe most common diagnoses after Covid were anxiety disorders.
- Zydus Cadila launches new product for COPD patients in IndiaDrug firm Zydus Cadila on Thursday said it is launching pressurized metered dose inhaler for patients suffering from Chronic Obstructive Pu...
- Cipla submits application with USFDA for generic version of asthma drugDrug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, ...
- Drug sales reveal our lifestyle woesIndians spent over Rs 1,36,000 cr on medicines in last one year ending September 2019. People spent over Rs 17,000 cr on cardiac drugs, aro...
- Homoeopathy sector may touch Rs 4,600 cr by 2012: AssochamIndian homoeopathy market may grow by 30% and touch Rs 4,600 crore by 2012, due to its effective treatment of chronic diseases, Assocham st...
- Ranbaxy launches osonase nasal sprayAllergic rhinitis affects 10-25 per cent of the global population and is believed to be a precursor for Asthma, Ranbaxy said.
- Ranbaxy launches osonase nasal sprayRanbaxy Laboratories Ltd on Wednesday launched its a nasal spray Osonase (Ciclesonide) aqueous in India used in the treatment of perennial ...
Load More
